JD Rowley

6.3k total citations · 1 hit paper
78 papers, 5.1k citations indexed

About

JD Rowley is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, JD Rowley has authored 78 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Hematology, 32 papers in Molecular Biology and 31 papers in Public Health, Environmental and Occupational Health. Recurrent topics in JD Rowley's work include Acute Myeloid Leukemia Research (55 papers), Acute Lymphoblastic Leukemia research (31 papers) and Chronic Myeloid Leukemia Treatments (27 papers). JD Rowley is often cited by papers focused on Acute Myeloid Leukemia Research (55 papers), Acute Lymphoblastic Leukemia research (31 papers) and Chronic Myeloid Leukemia Treatments (27 papers). JD Rowley collaborates with scholars based in United States, Japan and Netherlands. JD Rowley's co-authors include JW Vardiman, Richard A. Larson, MM Le Beau, HM Golomb, J Pedersen-Bjergaard, Giuseppina Nucifora, JR Testa, MO Diaz, CM Rubin and MA Bitter and has published in prestigious journals such as Blood and Leukemia.

In The Last Decade

JD Rowley

78 papers receiving 4.9k citations

Hit Papers

Nonrandom chromosome abno... 1981 2026 1996 2011 1981 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease
    1981 384 citations JD Rowley, HM Golomb et al. Blood profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
JD Rowley 3.8k 2.2k 1.6k 1.2k 581 78 5.1k
A Hagemeijer 3.2k 0.9× 2.1k 1.0× 1.5k 0.9× 1.5k 1.2× 866 1.5× 135 5.9k
CR Bartram 2.4k 0.6× 1.3k 0.6× 1.3k 0.8× 1.3k 1.1× 714 1.2× 68 3.8k
WM Crist 3.3k 0.9× 1.9k 0.9× 3.5k 2.1× 811 0.7× 819 1.4× 100 5.9k
Jochen Harbott 4.4k 1.2× 2.4k 1.1× 4.2k 2.6× 982 0.8× 1.0k 1.8× 166 7.3k
MT Daniel 5.3k 1.4× 2.9k 1.3× 1.4k 0.9× 1.9k 1.6× 753 1.3× 42 7.2k
JW Vardiman 2.2k 0.6× 1.1k 0.5× 857 0.5× 1.1k 0.9× 471 0.8× 52 3.3k
MM Le Beau 1.9k 0.5× 1.3k 0.6× 760 0.5× 733 0.6× 409 0.7× 54 3.1k
Nicole Dastugue 2.4k 0.6× 1.8k 0.8× 1.2k 0.7× 1.1k 0.9× 1.1k 1.9× 121 4.9k
Diane C. Arthur 2.0k 0.5× 1.0k 0.5× 945 0.6× 1.1k 0.9× 858 1.5× 78 4.1k
Karl S. Theil 2.3k 0.6× 1.2k 0.5× 798 0.5× 903 0.8× 449 0.8× 73 3.6k

Countries citing papers authored by JD Rowley

Since Specialization
Citations

This map shows the geographic impact of JD Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JD Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JD Rowley more than expected).

Fields of papers citing papers by JD Rowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JD Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JD Rowley. The network helps show where JD Rowley may publish in the future.

Co-authorship network of co-authors of JD Rowley

This figure shows the co-authorship network connecting the top 25 collaborators of JD Rowley. A scholar is included among the top collaborators of JD Rowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JD Rowley. JD Rowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Yuko, Hirofumi Kobayashi, Yasushi Suto, et al.. (2001). Chromosomal instability in chromosome band 12p13: multiple breaks leading to complex rearrangements including cytogenetically undetectable sub-clones. Leukemia. 15(8). 1193–1202. 24 indexed citations
2.
Rowley, JD. (2000). Molecular genetics in acute leukemia. Leukemia. 14(3). 513–517. 60 indexed citations
3.
Soderholm, Jon, Hirofumi Kobayashi, Chantal Mathieu, JD Rowley, & Giuseppina Nucifora. (1997). The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator. Leukemia. 11(3). 352–358. 81 indexed citations
4.
Larson, Richard A., MM Le Beau, J Pedersen-Bjergaard, et al.. (1993). Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA- topoisomerase II. Blood. 82(12). 3705–3711. 256 indexed citations
5.
Nucifora, Giuseppina, Richard A. Larson, & JD Rowley. (1993). Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood. 82(3). 712–715. 8 indexed citations
6.
Kobayashi, Hirofumi, Rafael Espinosa, MJ Thirman, et al.. (1993). Heterogeneity of breakpoints of 11q23 rearrangements in hematologic malignancies identified with fluorescence in situ hybridization.. Blood. 82(2). 547–51. 64 indexed citations
7.
Nucifora, Giuseppina, Richard A. Larson, & JD Rowley. (1993). Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood. 82(3). 712–715. 224 indexed citations
8.
9.
Rubin, CM, DC Arthur, WG Woods, et al.. (1991). Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy. Blood. 78(11). 2982–2988. 13 indexed citations
10.
Rubin, CM, Richard A. Larson, MA Bitter, et al.. (1987). Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia. Blood. 70(5). 1338–1342. 5 indexed citations
11.
Rubin, CM, Richard A. Larson, MA Bitter, et al.. (1987). Association of a chromosomal 3;21 translocation with the blast phase of chronic myelogenous leukemia. Blood. 70(5). 1338–1342. 70 indexed citations
12.
Rh, Jacobs, et al.. (1986). Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood. 67(6). 1765–1772. 211 indexed citations
13.
Larson, Richard A., SF Williams, MM Le Beau, et al.. (1986). Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood. 68(6). 1242–1249. 8 indexed citations
14.
15.
Rowley, JD, et al.. (1984). Cytogenetic studies on patients with chronic T cell leukemia/lymphoma. Blood. 63(5). 1028–1038. 4 indexed citations
16.
Rowley, JD, G. Alimena, O. Margaret Garson, et al.. (1982). A collaborative study of the relationship of the morphological type of acute nonlymphocytic leukemia with patient age and karyotype. Blood. 59(5). 1013–1022. 97 indexed citations
17.
Rowley, JD, HM Golomb, & JW Vardiman. (1981). Nonrandom chromosome abnormalities in acute leukemia and dysmyelopoietic syndromes in patients with previously treated malignant disease. Blood. 58(4). 759–767. 24 indexed citations
18.
Rowley, JD, et al.. (1981). Chromosome abnormalities in Down's syndrome patients with acute leukemia. Blood. 58(3). 459–466. 2 indexed citations
19.
Rowley, JD, et al.. (1980). Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosome. Blood. 56(2). 262–264. 2 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Hagemeijer Breakdown of academic impact, for papers by CR Bartram Breakdown of academic impact, for papers by WM Crist Breakdown of academic impact, for papers by Jochen Harbott Breakdown of academic impact, for papers by MT Daniel Breakdown of academic impact, for papers by JW Vardiman Breakdown of academic impact, for papers by MM Le Beau Breakdown of academic impact, for papers by Nicole Dastugue Breakdown of academic impact, for papers by Diane C. Arthur Breakdown of academic impact, for papers by Karl S. Theil
Rankless by CCL
2026